Curiomed advisors and contributors writing about what we believe — including where we disagree with the industry, where we think the consensus is wrong, and where we've changed our minds.
Half of the cases that come to us in week 4 of treatment elsewhere started as "just one infusion in Mexico." We have reviewed forty-three clinics offering variations on this offer. We currently recommend zero of them, and the reasons are not the ones you would guess from a news article.
Doctors, advisors, and operating team. Each writes from their actual specialty — not corporate communications.
Most hospital international-patient departments report to marketing, not the clinical chief. What this means in practice when you call, write, or visit — and the three signs you are talking to a sales team in scrubs.
It is the single most predictive question. It is also the one that surgeons are most prepared to answer honestly. Why patients don't ask, why we should change that, and how to phrase the question without sounding accusatory.
The instinctive answer is yes. The actual answer depends on three variables that almost no one weighs honestly: wait sensitivity, complication risk, and the patient's relationship to bureaucracy. A working framework.
A nicer room, faster admission, an English-speaking concierge. These are real services and they have a cost. They do not change the surgeon's hands or the protocol's effectiveness. Where the line actually is — and where it gets blurred on purpose.
Short reflections after particularly instructive consults. Always anonymized, sometimes uncomfortable, frequently the most-read posts of the month.
Recommendations we'd revise with hindsight. Industries we underestimated. Destinations we overrated. Patient categories we mis-served. Public corrections, on the record.
Industry shifts we are tracking — regulation, pricing, institutional changes. Read this before any major decision; the landscape has moved in ways your group chat hasn't caught up to.